Estimated time to complete activity: 1 hour
This activity is jointly provided by Postgraduate Institute for Medicine (www.pimed.com) and Medtelligence.
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Daiichi Sankyo, Inc.
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Medtelligence. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
A. John Camm, MD: Consulting Fees: Mitsubishi, Laguna, Bayer, BIOTRONIK, Richmond Pharmacology, Boehringer Ingelheim, Daiichi, Menarini, Novartis, St. Jude Medical, Bristol-Myers Squibb, Medtronic, Servier, Boston Scientific, and Eli Lilly and Company; Speakers Bureau: Pfizer; Data Safety Monitoring Board: BIOTRONIK and St. Jude Medical; Organizational (non-commercial): European Heart Rhythm Association.
Christopher B. Granger, MD: Research Grants: Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Medtronic Foundation, Pfizer, Sanofi-Aventis, Takeda, The Medicines Company, AstraZeneca, Daiichi Sankyo, Janssen Pharmaceuticals, and Armetheon; Consulting Fees (including CME): Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, GlaxoSmithKline, Hoffman-La Roche, Pfizer, Sanofi-Aventis, Takeda, The Medicine Company, AstraZeneca, Janssen Pharmaceuticals, Salix Pharmaceuticals, Gilead, and Medtronic.
Christian T. Ruff, MD, MPH: Consulting Fees: Daiichi Sankyo, Boehringer Ingelheim, Bayer, and Portola.
Jeffrey Weitz, MD: Consulting Fees: Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Pfizer, Portola, Janssen, and Isis Pharmaceuticals.
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Jan Schultz, MSN, RN, CHCP, and Judi Smelker-Mitchek, RN, BSN hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Medtelligence: Ben Caref, PhD; Pamela Clark - No financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation and Request for Credit
By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and physician assistants are entitled to receive up to 1.0 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:
- Read the learning objectives and faculty disclosures
- Participate in the activity
- Complete the post-test and activity evaluation
Physicians, nurse practitioners, and physician assistants who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
For any questions about the accreditation of this activity, please contact PIM at (800) 423-3576 or email@example.com.
COURSE VIEWING REQUIREMENTS
|Supported Browsers: |
Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above
|Supported Phones & Tablets: |
Android 4.0.3 and above
iPhone/iPad with iOS 7.0 or above